Satisfying Patient Expectations With Poly-L-Lactic Acid Soft Tissue Augmentation

April 2014 | Volume 13 | Issue 4 | Supplement Individual Articles | 40 | Copyright © April 2014


Danny Vleggaar MD,a Rebecca Fitzgerald MD,b and Z. Paul Lorenc MD FACSc

aHead of Cosmetic Dermatology in Private Practice, Geneva, Switzerland
bDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
cLorenc Aesthetic Plastic Surgery Center, New York, NY, USA

patents: US Patent 5/611,814–Resorbable Surgical Appliance for Use in Supporting Soft Tissue in a Superior Position; US Patent 60/950,423–Composition and Method of Use for Soft Tissue Augmentation/Drug Delivery; US Patent 12/797,710–Method for Measuring Change in Lip Size After Augmentation; and US Patent 13/604,012–Light Therapy Platform System.

REFERENCES

  1. Samson N, Fink B, Matts PJ, Dawes NC, Weitz S. Visible changes of female facial skin surface topography in relation to age and attractiveness perception. J Cosmet Dermatol. 2010;9(2):79-88.
  2. Fagien S, Carruthers JD. A comprehensive review of patient-reported satisfaction with botulinum toxin type A for aesthetic procedures. Plast Reconstr Surg. 2008;122(6):1915-1925.
  3. Carruthers A, Carruthers J. A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients’ perception of treatment outcomes. J Drugs Dermatol. 2009;8(10):924-929.
  4. Lewis MB, Bowler PJ. Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol. 2009;8(1):24-26.
  5. MacPherson S. Self-esteem and cosmetic enhancement. Plast Surg Nurs. 2005;25(1):5-20.
  6. American Society of Plastic Surgeons. Perception of the injection: ASPS survey reveals women confused but drawn to facial injectables. A Harris Interactive Survey [press release]. Arlington Heights, IL: American Society of Plastic Surgeons; 2006.
  7. ASDS Survey: Consumers rate soft-tissue treatments tops; choose dermatologic surgeons most often. American Society for Dermatologic Surgery. Available at: http://www.asds.net/_Media.aspx?id=7304. Accessed January 30, 2014.
  8. ASDS Survey: 3 in 10 consumers considering cosmetic procedures. American Society for Dermatologic Surgery. Available at: http://www.asds.net/_ Media.aspx?id=7204. Accessed January 30, 2014.
  9. 2013 ASDS Consumer Survey on Cosmetic Dermatologic Procedures. American Society for Dermatologic Surgery, Cosmetic Infographic. Available at: http://www.asds.net/_Media.aspx?id=7204 (download infographic pdf). Accessed January 30, 2014.
  10. Weinkle S, Lupo M. Attitudes, awareness, and usage of medical anti-aging treatments: results of a patient survey. J Clin Aesthet Dermatol. 2010;3(9):30-33.
  11. Mandy SH. Satisfying patient expectations with soft-tissue augmentation. Dermatol Online J. 2009;15(7):1-16.
  12. Vleggaar D, Fitzgerald R, Lorenc ZP, et al. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. J Drugs Dermatol. 2014;13(suppl 4):s44-s51.
  13. American Society of Plastic Surgeons. 2012 Plastic Surgery Statistics Report. Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2012-Plastic-Surgery-Statistics/full-plastic-surgery-statisticsreport.pdf. Accessed January 30, 2014.
  14. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118(suppl 3):s46-s54.
  15. Redaelli A, Forte R. Cosmetic use of polylactic acid: report of 568 patients. J Cosmet Dermatol. 2009;8(4):239-248.
  16. Palm MD, Woodhall KE, Butterwick KJ, Goldman MP. Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients. Dermatol Surg. 2010;36(2):161-170.
  17. Lee JY, Schulman MR, Skolnik RA. Modified poly-L-lactic acid injection technique: safety and efficacy of “cross-fanning” in non-HIV-related facial atrophy. Ann Plast Surg. 2010;64(4):435-441.
  18. Hanke CW, Redbord KP. Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol. 2007;6(2):123-128.
  19. Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: a prospective 3-year follow-up study. J Am Acad Dermatol. 2008;59(6):923-933.
  20. Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the poly-L-lactic acid implant for treatment of the nasolabial fold: 3-year follow-up evaluation. Aesthetic Plast Surg. 2008;32(5):753-756.
  21. Mazzuco R, Hexsel D. Poly-L-lactic acid for neck and chest rejuvenation. Dermatol Surg. 2009;35(8):1228-1237.
  22. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable poly-l-lactic acid: 3 years of aesthetic experience. Dermatol Surg. 2009;35(suppl 1):s344-s349.

AUTHOR CORRESPONDENCE

Rebecca Fitzgerald MDfitzmd@earthlink.net
Close Menu